Talan, Ellen .

HRN: 22-02-89  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2023
CEFTRIAXONE 1G (VIAL)
01/16/2023
01/23/2023
IV
2g
OD
Phyllodes Tumor
Waiting Final Action 
01/16/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/16/2023
01/23/2023
IV
600mg
Q6hrs
Phyllodes Tumor
Waiting Final Action 
01/21/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/21/2023
01/28/2023
IV
4.5g
Q 6H
Septicemia Sec To Infected L Breast Mass
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: